Bayer Mulls Dropping Monsanto Name as Brand Headache CureBy , , and
Executives aiming to build on consumer trust in Europe
The companies can “get beyond this image and reputation thing”
With Bayer AG’s proposed $66 billion purchase of Monsanto Co., the company that invented Aspirin is poised to take on one of the world’s biggest corporate headaches. A potential cure: dropping the Monsanto name.
To continue reading this article you must be a Bloomberg Professional Service Subscriber.
If you believe that you may have received this message in error please let us know.